Mandate

Vinge assist KGAL in the acquisition and project financing of the Bäckhammar wind farm

February 07, 2020 M&A Energy

Vinge has adviced a fund administrated by KGAL Investment Management GmbH & Co. KG with the acquisition and project financing of the Bäckhammar wind farm. Developed by the Swedish wind power developer Eolus Vind AB (publ), the Bäckhammar wind farm will have a total effect of approximately 130 MW. DNB Bank acted as lender.

The Vinge M&A team was led by Christoffer Thalin (Energy, M&A) who was supported by Mathias Lindquist (Environmental), Philip Åberg (Land, Grid) and Niklas Törnell (M&A).

The Vinge Banking & Finance team was led by Henrik Ossborn (Banking & Finance) who was supported by Fredrik Christiansson (Banking & Finance) and Jack Bengtsson (Banking & Finance).

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026